Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-06-15

Clinical Trial Update: Clinical Trial of Coenzyme Q10 and Lisinopril in Muscular Dystrophies [Phase 2, Phase 3]

View source ↗

Summary

This update notes the completion of a Phase 2/Phase 3 clinical trial evaluating Coenzyme Q10 in combination with Lisinopril for muscular dystrophies, including …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Coenzyme Q10 (Coenzyme Q10)
  • Lisinopril (Lisinopril)

Snippet

Sponsor: Cooperative International Neuromuscular Research Group | Conditions: Duchenne Muscular Dystrophy, Becker Muscular Dystrophy | Phase 2, Phase 3 | Status: COMPLETED